Preview

Сибирский онкологический журнал

Расширенный поиск

СОВРЕМЕНЫЕ ПРИНЦИПЫ КОМПЛЕКСНОГО ЛЕЧЕНИЯ ГЕНЕРАЛИЗОВАНОГО РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ (ОБЗОР ЛИТЕРАТУРЫ И АНАЛИЗ СОБСТВЕНОГО МАТЕРИАЛА)

Полный текст:

Аннотация

Обзор посвящен основным методам комплексного лечения генерализованного рака молочной железы. Проведен анализ международных исследований, целью которых явилась оценка эффективности хирургического лечения как этапа комплексного лечения больных раком молочной железы IV стадии. Рассмотрена роль современной лекарственной терапии как фактора, увеличивающего общую выживаемость

Об авторах

Д. Д. Пак
ФГБУ «Московский научно-исследовательский онкологический институт им. П.А. Герцена», г. Москва
Россия


Л. В. Болотина
ФГБУ «Московский научно-исследовательский онкологический институт им. П.А. Герцена», г. Москва
Россия


А. С. Сухотько
ФГБУ «Московский научно-исследовательский онкологический институт им. П.А. Герцена», г. Москва
Россия


Список литературы

1. Белохвостова А.С., Смирнова И.А., Енилеева А.А. Таргетная терапия в лечении HER2-позитивного рака молочной железы//Сибирский онкологический журнал. 2013. № 2 (56). С. 84-88

2. Чиссов В.И., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2010 году. М., 2012. 260 с

3. Adam R., Aloia T., Krissat J. et al. Is liver resection justified for patients with hepatic metastases from breast cancer?//Ann. Surg. 2006. Vol. 244 (6). P. 897-907

4. Andre F., Slimane K., Bachelot T. et al. Breast cancer with synchronous metastases: trends in survival during a 14-year period//J. Clin. Oncol. 2004. Vol. 22 (16). P. 3302-3308

5. Bafford A.C., Burstein H.J., Barkley C.R. et al. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival//Breast Cancer Res. Treat. 2009. Vol. 115 (1). P. 7-12

6. Baum M., Demicheni R., Hrushesky W. et al. Does sugery unfavourably perturb the «natural history» of early breast cancer by accelerating the appearance of distant metastases?//Eur. J. Cancer. 2005. Vol. 41. P. 508-515

7. Bathe O.F., Kaklamanos I.G., Moffat F.L. et al. Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancer//Surg. Oncol. 1999. Vol. 8 (1). P. 35-42

8. Blanchard D.K., Shetty P.B., Hilsenbeck S.G. et al. Association of surgery with improved survival in stage IV breast cancer patients//Ann. Surg. 2008. Vol. 247 (5). P. 732-738

9. Blazer D.G., Kishi Y., Maru D.M. et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases//J. Clin. Oncol. 2008. Vol. 26 (33). P. 5344-5351

10. Burzykowski T., Buyse M., Piccart-Gebhart M.J. et al. Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer//J. Clin. Oncol. 2008. Vol. 26 (12). P. 1987-1992

11. Buzdar A.U., Blumenschein G.R., Smith T.L. et al. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED)//J. Surg. Oncol. 1979. Vol. 12 (1). P. 27-40

12. Buyse M., Piccart-Gebhart M.J., Burzykowski T. et al. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer//J. Clin. Oncol. 2008. Vol. 26 (12). P. 1980-1986

13. Coffey J.C., Wang J. H., Smith M.J. Excisional surgery for cancer cure. Therapy at a cost//Lancer Oncol. 2003. Vol. 4. P. 760-768

14. Fields R.C., Jeffe D.B., Trinkaus K. et al. Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site metastasis//Ann. Surg. Oncol. 2007. Vol. 14 (12). P. 3345-3351

15. Friedel G., Pastorino U., Ginsberg R.J. et al. Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases//Eur. J. Cardiothorac. Surg. 2002. Vol. 22 (3). P. 335-344

16. Gnerlich J., Jeffe D.B., Deshpande A.D. et al. Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data//Ann. Surg. Oncol. 2007. Vol. 14 (8). P. 2187-2194

17. Greenberg P.A., Hortobagyi G.N., Smith T.L. et al. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer//J. Clin. Oncol. 1996. Vol. 14 (8). P. 2197-2205

18. Hackshaw A., Knight A., Barrett-Lee P. et al. Surrogate markers and survival in women receiving first-line combination anthracycline chemotherapy for advanced breast cancer//Br. J. Cancer. 2005. Vol. 93 (11). P. 1215-1221

19. Hanrahan E.O., Broglio K.R., Buzdar A.U. et al. Combined-modality treatment for isolated recurrences of breast carcinoma: update on 30 years of experience at the University of Texas M.D. Anderson Cancer Center and assessment of prognostic factors//Cancer. 2005. Vol. 104 (6). P. 1158-1171

20. Holmes F.A., Buzdar A.U., Kau S.W. et al. Combined-modality approach for patients with isolated recurrences of breast cancer (IV-NED): the M.D. Anderson experience//Breast Dis. 1994. Vol. 7. P. 7-20

21. Jackisch C. HER-2-positive metastatic breast cancer: optimizing trastuzumab-based therapy//Oncologist. 2006. Vol. 11. Suppl. 1. P. 34-41

22. Jakobs T.F., Hoffmann R.T., Schrader A. et al. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer//Cardiovasc. Interven. Radiol. 2009. Vol. 32 (1). P. 38-46

23. Le Scodan R., Stevens D., Brian E. et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy//J. Clin. Oncol. 2009. Vol. 27 (9). P.137-138

24. Mahner S., Schirrmacher S., Brenner W. et al. Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-Dglucose, conventional imaging and computed tomography for staging of breast cancer//Ann. Oncol. 2008. Vol. 19 (7). P.1249-1254

25. Miksad R.A., Zietemann V., Gothe R. et al. Progression-free survival as a surrogate endpoint in advanced breast cancer//Int. J. Technol. Assess. Health Care. 2008. Vol. 24 (4). P. 371-383

26. Olson J.A., Marcom P.K. Benefit or bias? The role of surgery to remove the primary tumor in patients with metastatic breast cancer//Ann. Surg. 2008. Vol. 247 (5) P. 739-740

27. O’Shaughnessy J. Extending survival with chemotherapy in metastatic breast cancer//Oncologist. 2005. Vol. 10 (3). P. 20-29

28. Rapiti E., Verkooijen H.M., Vlastos G. et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis//J. Clin. Oncol. 2006. Vol. 24 (18). P. 2743-2749

29. Rena O., Papalia E., Ruffini E. et al. The role of surgery in the management of solitary pulmonary nodule in breast cancer patients//Eur. J. Surg. Oncol. 2007. Vol. 33 (5). P. 546-550

30. Retsky M., Bonadonna G., Demicheli R. Hypothesis: induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients//Breast Cancer Res. 2004. Vol. 6 (4). P. 372-374

31. Rivera E., Holmes F.A., Buzdar A.U. et al. Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease//Breast J. 2002. Vol. 8 (1). P. 2-9

32. Ruiterkamp J., Ernst M.F., van de Poll-Franse L.V. et al. Surgical resection of the primary tumor is associated with improved survival in patients with distant metastatic breast cancer at diagnosis//Eur. J. Surg. Oncol. 2009. Vol. 35 (11). P. 1146-1151

33. Shien T., Kinoshita T., Shimizu C. et al. Primary tumor resection improves the survival of younger patients with metastatic breast cancer//Oncol. Rep. 2009. Vol. 21 (3). P. 827-832

34. Sinha P., Clements V.K., Miller S. et al. Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression//Cancer Immunol. Immunother. 2005. Vol. 54 (11). P. 1137-1142

35. Singletary S.E., Walsh G., Vauthey J.N. et al. A role for curative surgery in the treatment of selected patients with metastatic breast cancer//Oncologist. 2003. Vol. 8 (3). P. 241-251

36. Viadana E., Bross J., Pickren J. AmAutopsy Study of Some Routes of Dissemination of Cancer of the Breast//Br. J. Cancer. 1973. Vol. 27 (4). P. 336-340


Для цитирования:


Пак Д.Д., Болотина Л.В., Сухотько А.С. СОВРЕМЕНЫЕ ПРИНЦИПЫ КОМПЛЕКСНОГО ЛЕЧЕНИЯ ГЕНЕРАЛИЗОВАНОГО РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ (ОБЗОР ЛИТЕРАТУРЫ И АНАЛИЗ СОБСТВЕНОГО МАТЕРИАЛА). Сибирский онкологический журнал. 2013;(5):54-58.

For citation:


Pak D.D., Bolotina L.V., Suhotko A.S. Current aspects of comprehensive treatmentfor advanced breast cancer (literature review and analysis of original material). Siberian journal of oncology. 2013;(5):54-58. (In Russ.)

Просмотров: 343


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1814-4861 (Print)
ISSN 2312-3168 (Online)